{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:52:56Z","timestamp":1787788376435,"version":"build-2784847793"},"reference-count":51,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Around 2% of the population have intellectual disabilities. Over one-third people with intellectual disabilities (PwID) present with \u2018challenging behaviour\u2019, which nosologically and diagnostically is an abstract concept. Challenging behaviour is influenced by a range of bio-psycho-social factors in a population, which is unable to suitably comprehend and\/or communicate concerns. This predisposes to poor health and social outcomes. There is no evidence-based treatments for managing challenging behaviour. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are being trialled for a range of disorders, which are over-represented in PwID and provoke challenging behaviours, such as severe epilepsy, spasticity, post-traumatic stress disorder, social phobia, pain, etc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This perspective review explores the different conditions, which benefit from medicinal CBD\/THC preparations, by analysing recent literature from neurobiological, pre-clinical and clinical studies related to the topic. The evidence is synthesised to build an argument of the therapeutic benefits and challenges of medicinal cannabis to manage severe challenging behaviour in PwID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There is developing evidence of medicinal CBD\/THC improving psychiatric and behavioural presentations in general. In particular, there is emergent proof in certain key areas of influence of medicinal CBD\/THC positively supporting challenging behaviour, for example in children with neurodevelopmental disorders. However, there are significant challenges in employing such treatments in vulnerable populations such as PwID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Further clinical research for the considered use of medicinal CBD\/THC for challenging behaviour management in PwID is needed. Strong co-production with experts with lived experience is needed for further testing to be done in this exciting new area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811231209192","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T05:25:39Z","timestamp":1699421139000},"page":"1201-1208","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review"],"prefix":"10.1177","volume":"37","author":[{"given":"Laura","family":"Korb","sequence":"first","affiliation":[{"name":"Haringey Learning Disability Partnership, Barnet Enfield and Haringey Mental Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Tromans","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Leicester, Leicester, UK"},{"name":"Adult Learning Disability Service, Leicestershire Partnership NHS Trust, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhathika","family":"Perera","sequence":"additional","affiliation":[{"name":"North East London NHS Foundation Trust, London, UK"},{"name":"Division of Psychiatry, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagina","family":"Khan","sequence":"additional","affiliation":[{"name":"Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Burrows","sequence":"additional","affiliation":[{"name":"Royal Cornwall Hospitals NHS Trust, Truro, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Laugharne","sequence":"additional","affiliation":[{"name":"Cornwall Intellectual Disability Equitable Research (CIDER), University of Plymouth Peninsula School of Medicine, Truro, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hassiotis","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Allgar","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, Faculty of Health, University of Plymouth, Truro, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Efron","sequence":"additional","affiliation":[{"name":"Royal Children\u2019s Hospital, Melbourne, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Melbourne, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Maidment","sequence":"additional","affiliation":[{"name":"College of Life and Health Sciences, Aston School of Pharmacy, Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-6933","authenticated-orcid":false,"given":"Rohit","family":"Shankar","sequence":"additional","affiliation":[{"name":"Cornwall Intellectual Disability Equitable Research (CIDER), University of Plymouth Peninsula School of Medicine, Truro, UK"},{"name":"Peninsula Clinical Trials Unit, Faculty of Health, University of Plymouth, Truro, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"bibr1-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2020.237"},{"key":"bibr2-02698811231209192","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-02-21-5845"},{"key":"bibr3-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37570-y"},{"key":"bibr4-02698811231209192","doi-asserted-by":"publisher","DOI":"10.2174\/138955709787847921"},{"key":"bibr5-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0387-1"},{"key":"bibr6-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1007\/s40474-019-00175-9"},{"key":"bibr7-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2022.34"},{"key":"bibr8-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.43.s.3.3.x"},{"key":"bibr9-02698811231209192","first-page":"176","volume":"22","author":"Campbell CT","year":"2017","journal-title":"J Pediatr Pharmacol Therap"},{"key":"bibr10-02698811231209192","volume":"10","author":"Chesney E","year":"2020","journal-title":"Therap Adv Psychopharm"},{"key":"bibr11-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.05.005"},{"key":"bibr12-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2016.28"},{"key":"bibr13-02698811231209192","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-01-21-5809"},{"key":"bibr14-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14399"},{"key":"bibr15-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034362"},{"key":"bibr16-02698811231209192","unstructured":"Electronic Medicines Compendium (2021) Nabilone 1 mg Capsule. https:\/\/www.medicines.org.uk\/emc\/product\/12767\/smpc#gref"},{"key":"bibr17-02698811231209192","unstructured":"Electronic medicines compendium (2022) Epidyolex 100 mg\/ml oral solution. https:\/\/www.medicines.org.uk\/emc\/product\/10781#gref"},{"key":"bibr18-02698811231209192","unstructured":"Electronic Medicines Compendium (2022) Sativex Oromucosal Spray. https:\/\/www.medicines.org.uk\/emc\/product\/602\/smpc#gref"},{"key":"bibr19-02698811231209192","volume":"365","author":"Freeman TP","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"bibr20-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00229-7"},{"key":"bibr21-02698811231209192","first-page":"4","volume":"12","author":"Gore NJ","year":"2022","journal-title":"Int J Posit Behav Supp"},{"key":"bibr22-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0154"},{"key":"bibr23-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107079"},{"key":"bibr24-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018292"},{"key":"bibr25-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0376-4"},{"key":"bibr26-02698811231209192","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051154"},{"key":"bibr27-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2010.12.018"},{"key":"bibr28-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12775"},{"key":"bibr29-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13710"},{"key":"bibr30-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2018.08.030"},{"key":"bibr31-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2014.01.033"},{"key":"bibr32-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2015.02.043"},{"key":"bibr33-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06399-3"},{"key":"bibr34-02698811231209192","unstructured":"Royal College of Psychiatrists (2019) Cannabis-based medicinal products: Position Statement. https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/improving-care\/better-mh-policy\/position-statements\/ps05_19.pdf?sfvrsn=e91154ba_2"},{"key":"bibr35-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2409-8"},{"key":"bibr36-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120986393"},{"key":"bibr37-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1111\/jppi.12445"},{"key":"bibr38-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017406"},{"key":"bibr39-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3896"},{"key":"bibr40-02698811231209192","volume":"44","author":"Silva Junior EAD","year":"2021","journal-title":"Trends Psychiatry Psychother"},{"key":"bibr41-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02577-1"},{"key":"bibr42-02698811231209192","unstructured":"The National Institute for Health and Care Excellence (2021) Cannabis-based medicinal products. https:\/\/www.nice.org.uk\/guidance\/ng144"},{"key":"bibr43-02698811231209192","unstructured":"National Institute for Health and Care Excellence (2015) Challenging Behaviour and Learning Disabilities: Prevention and Interventions for People with Learning Disabilities Whose Behaviour Challenges. https:\/\/www.nice.org.uk\/guidance\/ng11"},{"key":"bibr44-02698811231209192","unstructured":"The National Institute for Health and Care Excellence (2022) Epilepsies in children, young people and adults. https:\/\/www.nice.org.uk\/guidance\/ng217\/resources\/epilepsies-in-children-young-people-and-adults-pdf-66143780239813"},{"key":"bibr45-02698811231209192","first-page":"1","author":"Timler A","year":"2023","journal-title":"Austr J Ageing"},{"key":"bibr46-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60072-0"},{"key":"bibr47-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1080\/19315864.2021.1992549"},{"key":"bibr48-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071178"},{"key":"bibr49-02698811231209192","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2013.08.015"},{"key":"bibr50-02698811231209192","volume-title":"J Dev Disabl","author":"Weiss J","year":"2003"},{"key":"bibr51-02698811231209192","volume-title":"ICD-11 for Mortality and Morbidity Statistics","author":"World Health Organization","year":"2018"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231209192","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811231209192","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231209192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:31Z","timestamp":1777507891000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811231209192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1177\/02698811231209192"],"URL":"https:\/\/doi.org\/10.1177\/02698811231209192","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}